C12N 2720/10032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2720/10032 (Use of virus as therapeutic agent, other than vaccine) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 4
- Assignees
- 2
- Inventors
- 11
- Latest grant
- 23 Jun 1992
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Use of a birnavirus alone or in combination therapy for the treatment of cancer12 Sep 2024US 2024/0299476 A1Probiogen AG
- Oncolytic virus based cancer therapy25 Jul 2024US 2024/0245739 A1
- Use of a birnavirus alone or in combimation therapy for the treatment of a disease caused by a nidovirus25 Jan 2024US 2024/0024390 A1Probiogen AG
- Combination of viral superinfection therapy with subthreshold doses of nivolumab plus ipilimumab in chronic HBV patients16 Dec 2021US 2021/0386804 A1
Most cited
By later US patents